Skip to main content
Premium Trial:

Request an Annual Quote

MDI, Launch Diagnostics Distributing MRSA Test

a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Molecular Detection and Launch Diagnostics today announced an exclusive distribution agreement for MDI's real-time PCR-based diagnostic for methicillin-resistant Staphylococcus aureus.

The agreement covers the UK, France, and Republic of Ireland. Other terms of the agreement were not disclosed.

The two firms also announced that the test, called Detect-Ready MRSA, has been launched in the UK and the Republic of Ireland.

Detect-Ready MRSA is a qualitative RT-PCR in vitro diagnostic test for detecting MRSA nasal colonization and is used to help prevent bacterial infection in hospitals and other healthcare settings.

Based in Wayne, Pa., MDI develops molecular diagnostic tests. Launch Diagnostics, headquartered in Longfield, UK, is a distributor of reagents, instruments, and related consumables.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.